Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
- 2021-06-28
- RCT · n = 42
- Digestive diseases (Basel, Switzerland) 40(3)
- Kousuke Kubota
- Haruki Uojima
- Xue Shao
- Shuichiro Iwasaki
- Hisashi Hidaka
- Naohisa Wada
- Takahide Nakazawa
- Akitaka Shibuya
- Makoto Kako
- Wasaburo Koizumi
- PubMed: 34348263
- DOI: 10.1159/000518067
- High evidence
- Clinical
the admission rates were 30.9% and 9.8% in groups A and B, respectively. Additional L-carnitine significantly reduced the admission rate (p = 0.028).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 1,500 mg/day